Praxis Precision Medicines Newsroom

Praxis Precision Medicines to Present at J.P. Morgan Healthcare Conference

GlobeNewswireJan 6 08:00 ET

Express News | Praxis Precision Medicines : Sales Agreement Prospectus Covering Offering up to $250 Mln of Common Stock That May Be Issued From Time to Time

ReutersDec 23, 2024 16:15 ET

Express News | Praxis Precision Medicines Inc Files for Mixed Shelf- SEC Filing

ReutersDec 23, 2024 16:14 ET

Truist Financial Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating

Moomoo NewsDec 20, 2024 13:31 ET · Ratings

Praxis Precision Medicines (PRAX) Gets a Buy From Truist Financial

TipRanksDec 20, 2024 12:39 ET · Ratings

Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted For Relutrigine In Dravet Syndrome; Praxis Plans To Initiate An All-DEE Trial (EMERALD), Inclusive Of Dravet Syndrome, In 1H2025

BenzingaDec 18, 2024 08:14 ET

Express News | Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted for Relutrigine in Dravet Syndrome

ReutersDec 18, 2024 08:00 ET

9 Health Care Stocks With Whale Alerts In Today's Session

BenzingaDec 16, 2024 12:35 ET

We're Not Very Worried About Praxis Precision Medicines' (NASDAQ:PRAX) Cash Burn Rate

Simply Wall StDec 13, 2024 06:50 ET

H.C. Wainwright Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $120

Moomoo NewsDec 12, 2024 06:31 ET · Ratings

Praxis Precision Med Price Target Maintained With a $120.00/Share by HC Wainwright & Co.

Dow JonesDec 12, 2024 06:28 ET · Ratings

Promising Pipeline and Strategic Developments Position Praxis Precision Medicines for Market Expansion

TipRanksDec 12, 2024 06:16 ET

Jefferies Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Raises Target Price to $305

Moomoo NewsDec 11, 2024 14:31 ET · Ratings

Express News | Praxis Precision Medicines Inc : Jefferies Raises Target Price to $305 From $144

ReutersDec 11, 2024 07:47 ET

GeneDx Announces Biogen, Praxis Precision Medicines And Stoke Therapeutics As The Founding Partners To Its Patient Access Program For Pediatric Epilepsy, Which Provides Access To Whole Exome Sequencing.

BenzingaDec 5, 2024 08:54 ET

GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients With New Partners

BusinesswireDec 5, 2024 08:30 ET

Praxis Precision Medicines to Present at Upcoming December Investor Conferences

GlobeNewswireDec 3, 2024 08:00 ET

Praxis Precision Medicines to Showcase Updates From Largest Epilepsy Pipeline of Precision Epilepsy Programs at the 2024 American Epilepsy Society Annual Meeting

GlobeNewswireNov 26, 2024 08:00 ET

Praxis Solutions Welcomes Andre Hatibi as Senior Vice President of Business Development

PR NewswireNov 21, 2024 06:00 ET

Piper Sandler Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $270

Moomoo NewsNov 12, 2024 07:31 ET · Ratings